In less than a year, the Animal Care division has received orders for five vetIQure TSE systems and several treatment kits from one single account. The vetIQure TSE system is a patented solution designed to improve clinical outcomes for veterinarians treating cancer and is produced for veterinary use only. It provides the veterinarians with a precise and minimally invasive method to administer chemotherapy directly into solid tumours and helps to maximise its effect whilst minimising damage to surrounding healthy tissue.
This targeted therapy is developed to reduce risks for ablations and destruction and to stimulate the patient's own immune system to attack the tumour cells and can therefor lead to better outcomes with fewer side effects for the animals
"We are delighted to receive another order for our vetIQure TSE system, especially from such an esteemed provider," says
For further information please contact:
Phone: +46 (0)10-218 93 00
E-mail: ir@chemotech.se
ChemoTech is a Swedish medical technology company based in
https://news.cision.com/chemotech/r/new-order-received-for-the-innovative-tse-cancer-treatment-technology,c3926491
https://mb.cision.com/Main/14967/3926491/2596191.pdf
https://news.cision.com/chemotech/i/shutterstock-550316641,c3266219
(c) 2024 Cision. All rights reserved., source